ClinicalTrials.gg
RecruitingNCT07180550HIIT-HIFT-FTUpdated Mar 10, 2026

Acute Effects of High-intensity Interval Aerobic and Functional Training at Different Intensities

An interventional study of High-intensity interval training, running and High-intensity interval training, cycling in High Intensity Interval Training (Cycling), High Intensity Interval Training (Running) and High Intensity Functional Training, sponsored by European University Miguel de Cervantes. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by European University Miguel de Cervantes · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Moderate-intensity physical exercise is widely recognized for its health benefits, yet time constraints limit adherence. High-intensity interval training (HIIT) has gained popularity as a more time-efficient alternative, eliciting significant cardiovascular, respiratory, metabolic, and neuromuscular responses. More recently, functional strength exercises have been integrated into high-intensity training, leading to high-intensity functional training (HIFT) and moderate-intensity functional training (MIFT). However, the acute physiological responses to these modalities remain underexplored compared to traditional HIIT (running or cycling) and strength training. This study aims to assess and compare the acute cardiovascular, metabolic, and neuromuscular responses of HIFT, MIFT, HIIT, and traditional strength training in healthy, physically active adults to inform their potential application in special populations.

Read the detailed description

Moderate-intensity physical exercise has long been a cornerstone in promoting health and well-being. However, despite its well-documented benefits, an exclusive focus on this training modality may overlook some important limitations. One such limitation is the challenge of dedicating sufficient time to physical activity to achieve health and fitness goals. Given this constraint, recent years have witnessed a significant shift in training modalities, moving away from continuous moderate-intensity exercise approaches [e.g., 55-70% of peak heart rate (HRpeak) or 40-60% of maximal oxygen uptake (VO₂max)] toward higher-intensity interval training protocols (e.g., >90% HRpeak or >85% VO₂max), thereby enhancing time efficiency and enjoyment for practitioners.

In this context, the most common type of training is high-intensity interval training (HIIT). HIIT consists of performing brief, high-intensity cyclic and continuous efforts (e.g., running or cycling) separated by predefined rest periods while using a single exercise modality. These short efforts (e.g., 1 to 4 minutes) at high intensity, whether cycling or running, elicit substantial cardiovascular, respiratory, metabolic, and neuromuscular stimuli, which can persist for hours after the workout.

Recently, this training approach has incorporated functional strength exercises-movements that mimic natural movement patterns and have practical applications in daily life-performed at high intensity [e.g., >75% of one-repetition maximum (1RM)] and following a circuit-based exercise organization (i.e., performing one exercise after another rather than using simple sets and pauses), a modality commonly referred to as high-intensity functional training (HIFT). Reducing the intensity of prescribed functional exercises (e.g., 60% 1RM) brings the training program closer to the demands of daily activities, a modality commonly known as moderate-intensity functional training (MIFT). However, both HIFT and MIFT define their intensity theoretically, based on the relative intensity concerning the maximum dynamic concentric strength that individuals can develop in each exercise (%1RM). Meanwhile, the cardiovascular, respiratory, metabolic, and neuromuscular demands of these methodologies remain largely unexplored compared to running-based HIIT (HIIT-R), cycling-based HIIT (HIIT-C), and traditional strength training with moderate (M-FT) and high (H-FT) loads in healthy, physically active adults. Therefore, before these methods can be applied to special populations (e.g., individuals with chronic cardiovascular or respiratory diseases, cancer, or older adults), it is essential to first understand their acute response in healthy, physically active individuals.

02

Conditions studied

  • High Intensity Interval Training (Cycling)
  • High Intensity Interval Training (Running)
  • High Intensity Functional Training
  • Moderate Intensity Functional Training
  • High Intensity Traditional Strength Training
  • Moderate Intensity Traditional Strength Training

Keywords

  • Metabolic demand
  • Oxygen consumption
  • Heart rate variability
  • Interval training
  • Strength training
03

In context

Lead sponsor

European University Miguel de Cervantes is the lead sponsor of 16 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be 18 years of age or older.
  • Have at least 6 months of experience in strength training with intensities greater than 75% of one maximum repetition (1-RM).
  • Be classified as active according to the International Physical Activity Questionnaire (IPAQ) score.

Exclusion criteria

Exclusion Criteria:

  • Musculoskeletal injury within the 6 months prior to the first visit to the laboratory.
  • Recent major surgery (\<3 months).
  • Having a medical condition in which physical activity is (assessed with the Physical Activity Readiness Questionnaire, PAR-Q+).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
27 participants (estimated)

Study arms

  • Experimental
    High-intensity interval training (running)

    Participants will perform a high-intensity interval training based on six sets of 2-minute runs at an intensity of 90-95% of the maximal aerobic speed (MAS) on a treadmill. The recovery between each set will be 2 minutes, during which the subject will walk at an intensity of 50-60% of MAS.

    Other: High-intensity interval training, running

  • Experimental
    High-intensity interval training (cycling)

    Participants will perform a high-intensity interval training based on six sets of 2-minute cycling will be performed at an intensity of 90-95% of the maximal heart rate on a stationary bike. The recovery between each set will be 2 minutes, during which the subject will cycle at an intensity of 50-60% of maximal heart rate.

    Other: High-intensity interval training, cycling

  • Experimental
    High-intensity functional training

    Participants will perform a high-intensity functional training based on three sets of six repetitions will be performed at 80% of the one repetition maximum (1-RM) for six exercises. The recovery between exercises will be the minimum time required to switch from one exercise to the next, and between sets, it will be two minutes. Participants will be instructed to move the load as quickly as possible during each repetition.

    Other: High-intensity functional training

  • Experimental
    Moderate-intensity functional training

    Participants will perform a moderate-intensity functional training based on three sets of six repetitions will be performed at 60% of the 1-RM for six exercises. The recovery between exercises will be the minimum time required to switch from one exercise to the next, and between sets, it will be two minutes. Participants will be instructed to move the load as quickly as possible during each repetition.

    Other: Moderate-intensity functional training

  • Experimental
    High-intensity traditional training

    Participants will perform a high-intensity traditional training based on three sets of six repetitions will be performed at 80% of the 1-RM for six exercises. The recovery after each set will be two minutes of passive rest. Participants will be instructed to move the load as quickly as possible during each repetition.

    Other: High intensity traditional strength training

  • Experimental
    Moderate-intensity traditional training

    Participants will perform a high-intensity traditional training based on three sets of six repetitions will be performed at 60% of the 1-RM for six exercises. The recovery after each set will be two minutes of passive rest. Participants will be instructed to move the load as quickly as possible during each repetition.

    Other: Moderate intensity traditional strength training

Interventions

  • OtherHigh-intensity interval training, running

    Six sets of 2-minute runs will be performed at an intensity of 90-95% of the maximal aerobic speed (MAS) on a treadmill. The recovery between each set will be 2 minutes, during which the subject will walk at an intensity of 50-60% of MAS.

  • OtherHigh-intensity interval training, cycling

    Six sets of 2-minute cycling will be performed at an intensity of 90-95% of the maximal heart rate on a stationary bike. The recovery between each set will be 2 minutes, during which the subject will cycle at an intensity of 50-60% of maximal heart rate.

  • OtherHigh-intensity functional training

    Three sets of six repetitions will be performed at 80% of the one repetition-maximum (1-RM) for six exercises. The recovery between exercises will be the minimum time required to switch from one exercise to the next, and between sets, it will be two minutes. Participants will be instructed to move the load as quickly as possible during each repetition.

  • OtherModerate-intensity functional training

    Three sets of six repetitions will be performed at 60% of the 1-RM for six exercises. The recovery between exercises will be the minimum time required to switch from one exercise to the next, and between sets, it will be two minutes. Participants will be instructed to move the load as quickly as possible during each repetition.

  • OtherModerate intensity traditional strength training

    Three sets of six repetitions will be performed at 60% of the 1-RM for six exercises. The recovery after each set will be two minutes of passive rest. Participants will be instructed to move the load as quickly as possible during each repetition.

  • OtherHigh intensity traditional strength training

    Three sets of six repetitions will be performed at 80% of the 1-RM for six exercises. The recovery after each set will be two minutes of passive rest. Participants will be instructed to move the load as quickly as possible during each repetition.

06

What researchers measure

Primary outcomes

  1. Heart rate variability

    The heart rate variability (HRV) of the participants will be assessed by monitoring their heart rate, which reflects the variation in the intervals between heartbeats (R-R intervals). This measure is a useful tool in monitoring patient health, as it estimates the balance between the sympathetic and parasympathetic activity of the autonomic nervous system. To evaluate heart rate variability, a Polar H10 heart rate monitor (Polar Electro Oy, Kempele, Finland) and a mobile application, specifically Elite HRV, will be used. Heart rate variability will be monitored daily during the week leading up to the initial assessment visits. Participants will be instructed to take the measurement for the first 5 minutes upon waking and while fasting. Subsequently, heart rate variability will be assessed immediately before each training condition, as well as immediately after, at 2, 24, 48, and 72 hours after finishing each training condition.

    Time frame: Week 0 (baseline), Weeks 1-4 (during intervention and 24, 48, and 72 hours post-intervention)

Secondary outcomes

  1. Post-exercise oxygen debt

    The oxygen debt (EPOC) will be calculated every minute during the 12 minutes following the completion of exercise using the following formula: EPOC (L·min-¹) = oxygen consumption (VO2) post-exercise (L·min-¹) - VO2 at rest (L·min-¹). Subsequently, EPOC will be converted into energy expenditure, using the conversion of 1L of O2 = 4.64 kcal, to exclude the rapid glycolytic resynthesis of adenosine triphosphate (ATP) as part of the conversion of O2 consumption into energy expenditure (EE).

    Time frame: Weeks 2-4 (after every intervention session)

  2. Delayed onset muscle soreness

    This will be recorded using a visual analog scale, with a score ranging from 0 (no pain) to 10 (worst possible pain), immediately after the exercise and at 24, 48, and 72 hours after completing the training session. To quantify the pain and standardize the measurements, participants will be asked to perform 5 rapid repetitions of sitting down and standing up from a chair, as well as 5 rapid push-up repetitions, after which they will respond to the question, "How sore are your legs/arms?".

    Time frame: Weeks 2-4 (24, 48, and 72 hours post-intervention)

  3. Satisfaction with the type of training

    It will be evaluated at the end of each session using a numerical scale from 0 to 10, where the highest score indicates maximum satisfaction with the type of training.

    Time frame: Weeks 2-4 (right after every intervention session and 24 hours post-intervention)

  4. Subjective post-exercise fatigue

    It will be measured using the perceived fatigue scale (ROF). This is a numerical scale that ranges from 0 (no fatigue) to 10 (total fatigue or exhaustion), with five descriptors and five diagrams to help the individual understand the scale and make an assessment. This evaluation will be conducted immediately after the exercise session and 24 hours after completion.

    Time frame: Weeks 2-4 (right after every intervention session and 24 hours post-intervention)

  5. Perceived effort

    It will be monitored during the six experimental conditions using the Rate of Perceived Exertion (RPE CR-10) scale. The RPE will be recorded after each set or circuit round. Immediately after completing the last set of each condition, participants will be asked to indicate their perceived effort for the entire session. Subsequently, it will be recorded at 24, 48, and 72 hours after the completion of each condition.

    Time frame: Weeks 2-4 (right after every intervention session and 24, 48, and 72 hours post-intervention)

  6. Gas exchange analysis

    The values of mean and peak gas exchange (ml·kg-1·min-1) during the intervention sessions. The gas analyzer that will be used in this study (Cortex Metalyzer 3B, Leipzig, Germany).

    Time frame: Weeks 2-4 (during intervention sessions)

Other outcomes

  1. Physical activity levels

    The physical activity levels of the participants will be evaluated using the International Physical Activity Questionnaire (IPAQ). This questionnaire consists of 7 questions that will allow for the stratification of physical activity levels.

    Time frame: Week 0 (baseline)

  2. Cardiorespiratory fitness

    The mean and peak values for gas exchange will be recorded in ml/kg·min. The gas analyzer used in this study is the Cortex Metalyzer 3B (Leipzig, Germany). Cardiorespiratory capacity will be determined using a maximum stress test: Incremental Ramp Exercise Test on Treadmill (H/P/Cosmos Pulsar, Southern, Germany): The test will begin with a 2-minute warm-up at 7 km/h and a 1% incline. Following this, the test will start at 9 km/h and will increase by 0.5 km/h each minute until exhaustion.

    Time frame: Week 1 (baseline)

  3. Cardiorespiratory fitness

    The mean and peak values for gas exchange will be recorded in ml/kg·min. The gas analyzer used in this study is the Cortex Metalyzer 3B (Leipzig, Germany). Cardiorespiratory capacity will be determined using a maximum stress test: Incremental Ramp Exercise Test on Bicycle (Wattbike AtomX, Nottingham, England): The test will begin with a 2-minute warm-up at 100W. After this, the power will increase by 20W each minute until exhaustion, defined as the point at which the participant cannot maintain a cadence of ≥50 revolutions per minute (rpm).

    Time frame: Week 1 (baseline)

  4. 1-RM detection

    Each participant will perform the 1-RM test for each exercise, completing the full range of motion with a load approximately equal to 3-RM. The load will be increased by 10 kg if the participant is able to complete the repetition and decreased by 5 kg if they are unable to do so. The test will conclude when the participant is unable to lift a load in two consecutive attempts separated by 2 minutes.

    Time frame: Week 1 (baseline)

  5. Handgrip strength

    Handgrip strength will be assessed using the hand-held Jamar® Plus Smart Dynamometer (Patterson Medical Ltd., Sammons Preston, Nottinghamshire, UK). Manual grip strength will be recorded on both limbs and the dynamometer will be adjusted to hand size prior to testing. The participant's elbow should be in 90° flexion and the forearm fully supported on a table.

    Time frame: Week 0 (baseline)

  6. Bioimpedance

    The NUTRILAB bioimpedance device (AKERN Srl, Florence, Italy) will be used. This non-invasive method measures the body's resistance and reactance of the body to the passage of a low-intensity electric current and enables the determination of various body parameters. Bioimpedance provides accurate data on body composition. Users will be instructed to remove all metal-containing objects and remain in a supine position on a couch during the measurements, with the legs in 45° abduction, the shoulders in 30° abduction relative to the center of the body and the hands in pronation. After cleaning the skin with alcohol, two adhesive electrodes (Biatrodes Akern Srl, Florence, Italy) will be placed on the surface of the right hand and two on the right foot. The measurement results will be given in different unit measures depending on the specific variable assessed.

    Time frame: Week 0 (baseline)

  7. Muscle thickness

    Muscle thickness the vastus lateralis of the dominant side will be measured using a real-time B-mode ultrasound device with a linear transducer. A water-soluble, hypoallergenic transmission gel will be applied to the probe, to serve as a conductive interface between the probe and the participant's skin. Sufficient gel will be used to prevent compression of the muscle by the probe.

    Time frame: Week 0 (baseline)

  8. Speed-velocity profile

    Three intensities will be determined based on the body weight obtained in the first assessment session: weights corresponding to 50% (low load), 75% (medium load), and 100% (high load) of body weight can be selected. To create the speed-velocity profile, three maximum explosive repetitions will be performed in each of the strength exercises at each load percentage, with a three-minute rest between sets.

    Time frame: Week 1 (baseline)

  9. Weight

    Weight will be assess on kilograms (kg)

    Time frame: Week 1 (baseline)

  10. Height

    Height will be assess on centimeters (cm)

    Time frame: Week 1 (baseline)

  11. Cardiovascular response

    The values for minimum, average heart rate (HR) and peak heart rate (HR) will be recorded using a polar H10 chest strap (Polar Electro Oy, Kempele, Finland) during the maximal stress tests.

    Time frame: Week 1 (baseline)

07

Study locations

1 of 1 sites recruiting
  • Miguel de Cervantes European University
    Valladolid, Valladolid 47012, Spain
    Recruiting
    • Francisco Javier Gutiérrez Pecharromán · Contactdit@uemc.es · +34 983001000
    • Susana López-Ortiz, PhD · Contactslopezo@uemc.es · +34 983001000
    • María Merino-País, MsC · Sub investigator
    • Celia García-Chico, MsC · Sub investigator
    • Sergio Maroto-Izquierdo, PhD · Sub investigator
    • Saúl Peñín-Grandes, PhD · Sub investigator
    • Alejandro Santos-Lozano, PhD · Sub investigator
    • Pablo Elpidio García Granja, PhD · Principal investigator
    • Carlos Baladrón Zorita, PhD · Principal investigator
    • Miguel Matesanz González, BSc · Sub investigator
    • Susana López-Ortiz, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for Jan 2027, 14 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2025
First posted
Sep 18, 2025
StartActual
Oct 12, 2025
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 31, 2027
Last update
Mar 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07180550
Lead sponsor
European University Miguel de Cervantes
Collaborators
Hospital Clínico Universitario de Valladolid
Responsible party
Sponsor
First posted
Sep 18, 2025
Start date
Oct 12, 2025
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Mar 10, 2026

Study contacts

Susana López Ortiz, PhD
Contact
cbaladron@icicor.es
983001000
Susana López Ortiz, PhD
Contact
cbaladron@icicor.es

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion